Lineage Cell Therapeutics
LCTX
#8221
Rank
NZ$0.26 B
Marketcap
$1.40
Share price
1.22%
Change (1 day)
-34.18%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$58.78 M

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are NZ$58.78 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$61.66 M-24.32%
2022-12-31NZ$81.47 M-33.47%
2021-12-31NZ$0.12 B589.14%
2020-12-31NZ$17.77 M-15.9%
2019-12-31NZ$21.13 M50.56%
2018-12-31NZ$14.03 M11.02%
2017-12-31NZ$12.64 M-27.42%
2016-12-31NZ$17.41 M-34.55%
2015-12-31NZ$26.61 M71.21%
2014-12-31NZ$15.54 M-17.42%
2013-12-31NZ$18.82 M183.89%
2012-12-31NZ$6.63 M18.37%
2011-12-31NZ$5.6 M12.33%
2010-12-31NZ$4.98 M51.79%
2009-12-31NZ$3.28 M-64.58%
2008-12-31NZ$9.27 M120.53%
2007-12-31NZ$4.2 M17.77%
2006-12-31NZ$3.57 M13.24%
2005-12-31NZ$3.15 M91.2%
2004-12-31NZ$1.64 M-69.39%
2003-12-31NZ$5.38 M5.71%
2002-12-31NZ$5.09 M3.72%
2001-12-31NZ$4.91 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$43.37 M-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA